Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Insulin Intervention followed by Pioglitazone and Metformin in Type 2 Diabetes
2006-002354-30Phase 2Completed
- Sponsor
- Takeda
- Start
- Jun 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pioglitazone, metformin and human insulin in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Primary endpoint: HbA1c response and stability on oral therapy. Started Jun 2006; status: completed.
02
Drugs
pioglitazonemetforminhuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002354-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002354-30.